PLOS | Jotup

Dogs Thrive on Vegan Diets, Demonstrates the Most Comprehensive Study So Far

Retrieved on:

火曜日, 4月 23, 2024

WINCHESTER, ENGLAND, Apr 24, 2024 - (ACN Newswire) - The longest, most comprehensive peer-reviewed study so far has demonstrated that dogs fed nutritionally-sound vegan diets maintain health outcomes as well as dogs fed meat.

Key Points:

WINCHESTER, ENGLAND, Apr 24, 2024 - (ACN Newswire) - The longest, most comprehensive peer-reviewed study so far has demonstrated that dogs fed nutritionally-sound vegan diets maintain health outcomes as well as dogs fed meat.
The study was particularly interesting, given recent suggestions that peas might contribute to heart disease in dogs in the US.
In the current study, dogs were fed pea-based vegan pet food, for one year.
Our study offers new evidence on outcomes in clinically healthy dogs who thrive without consumption of animal-derived ingredients.

Sara Rouhi joins AIP Publishing as Director of Open Science and Publishing Innovation

Retrieved on:

火曜日, 4月 30, 2024

Society, American Institute of Physics, CPO, PLOS, Communication, Partnership, SSP, Research, Public, AIP, Multimedia, Emerging, Management

"AIPP has a storied history as researcher-focused non-profit committed to putting science first," Rouhi said. "I'm honored to join a leadership team not only committed to forging an equitable open science path but also deeply invested in building a workplace culture grounded in humility, experimentation, and embracing change. AIPP -- thanks to its cultural transformation and its open science investment -- stands poised to contribute meaningfully and substantively to the furthering of open science globally."

Key Points:

MELVILLE, N.Y., April 30, 2024 /PRNewswire/ -- AIP Publishing (AIPP) announced today that Sara Rouhi has joined the organization in the new role of Director of Open Science and Publishing Innovation.
AIPP -- thanks to its cultural transformation and its open science investment -- stands poised to contribute meaningfully and substantively to the furthering of open science globally."
Rouhi joins AIP Publishing from Public Library of Science (PLOS) where she was Regional Director, Publishing Development, The Americas.
I'm thrilled that Sara will join us in driving open science innovation that truly benefits the physical sciences community."

OMRON Donates Some 3,200 Units of Blood Pressure Monitors to Global Blood Pressure Screening Campaign on World Hypertension Day

Retrieved on:

金曜日, 4月 26, 2024

MMM was established by the International Society of Hypertension in 2017, and since then the Company has participated in this global campaign.

Key Points:

MMM was established by the International Society of Hypertension in 2017, and since then the Company has participated in this global campaign.
May 17 is set to be the World Hypertension Day, and there are diverse events organized by regional societies and committees worldwide.
Blood pressure fluctuates throughout the day in response to a variety of factors such as temperature, humidity, and physical factors including stress.
Therefore, it is essential to monitor blood pressure at home in addition to regular health checkups at medical facilities.

OMRON Donates Some 3,200 Units of Blood Pressure Monitors to Global Blood Pressure Screening Campaign on World Hypertension Day

Retrieved on:

金曜日, 4月 26, 2024

MMM was established by the International Society of Hypertension in 2017, and since then the Company has participated in this global campaign.

Key Points:

MMM was established by the International Society of Hypertension in 2017, and since then the Company has participated in this global campaign.
May 17 is set to be the World Hypertension Day, and there are diverse events organized by regional societies and committees worldwide.
Blood pressure fluctuates throughout the day in response to a variety of factors such as temperature, humidity, and physical factors including stress.
Therefore, it is essential to monitor blood pressure at home in addition to regular health checkups at medical facilities.

Our laser technique can tell apart elephant and mammoth ivory – here’s how it may disrupt the ivory trade

Retrieved on:

木曜日, 4月 25, 2024

In recent years, the global trade in elephant ivory has faced significant restrictions in an effort to protect dwindling elephant populations.

Key Points:

In recent years, the global trade in elephant ivory has faced significant restrictions in an effort to protect dwindling elephant populations.
The sale of mammoth ivory, sourced primarily from long-extinct species, however, remains unregulated.
But it’s a significant challenge for customs and law enforcement agencies to distinguish between ivory from extinct mammoths and living elephants.
Now our new study, published in PLOS ONE, presents a major breakthrough – using a well known laser technique to tell mammoth and elephant ivory apart.

This activity not only has commercial implications. It also raises significant ethical and environmental concerns. That’s because it disturbs preserved ecosystems and involves the extraction of resources that have great value to paleontological science.

Laser insights

We use a non-invasive laser technique known as Raman spectroscopy to identify the origin of a piece of ivory.
The technique works by directing a laser light onto the ivory sample.
This released light scatters back with more or less energy than the initial laser light sent to the sample.

Important implications

This makes it an ideal tool for customs officials who need to make rapid decisions.
Our study was conducted on a benchtop spectrometer (a device which breaks up light by wavelength) within a laboratory.
We are working with Worldwide Wildlife Hong Kong and the Foreign and Commonwealth Development Office to develop this technique.

Rebecca Shepherd receives funding from EPSRC and the FCDO.

ACTREC Researchers Show Cancer Treatments May be Promoting its Spread

Retrieved on:

木曜日, 3月 28, 2024

Research, Education, ACTREC, Glomus tumor, Neoplasm, DNA, Mouse, PLOS One, Radiation, Protein, Treatment, PLOS, Blood, Lymphatic system, Metastasis

MUMBAI, India, March 28, 2024 /PRNewswire/ -- Cancer spreads from its primary tumor to other parts of the body via blood or the lymphatic system in a process termed 'metastasis'. This usually represents an advanced stage in the disease's progression and tends to be fatal. Therefore, preventing metastasis remains a major goal in oncology.

Key Points:

In a step towards these efforts, Prof. Indraneel Mittra from the Advanced Centre for Treatment, Research and Education in Cancer (ACTREC), India, has shed light on what causes metastasis.
Their findings, published in PLOS One result from experiments in mice grafted with human breast cancer cells (xenografts) to induce cancer.
Prof. Mittra concludes,"Future long-term experiments should explore whether cfChP-deactivating agents given concurrently with anti-cancer treatments could help prevent metastatic spread.
When used as adjuncts to cancer treatment, these agents would have the added advantage of preventing some of the toxic side effects of chemotherapy and radiotherapy."

ACTREC Researchers Show Cancer Treatments May be Promoting its Spread

Retrieved on:

木曜日, 3月 28, 2024

Research, Education, ACTREC, Glomus tumor, Neoplasm, DNA, Mouse, PLOS One, Radiation, Protein, Treatment, PLOS, Blood, Lymphatic system, Metastasis

MUMBAI, India, March 28, 2024 /PRNewswire/ -- Cancer spreads from its primary tumor to other parts of the body via blood or the lymphatic system in a process termed 'metastasis'. This usually represents an advanced stage in the disease's progression and tends to be fatal. Therefore, preventing metastasis remains a major goal in oncology.

Key Points:

In a step towards these efforts, Prof. Indraneel Mittra from the Advanced Centre for Treatment, Research and Education in Cancer (ACTREC), India, has shed light on what causes metastasis.
Their findings, published in PLOS One result from experiments in mice grafted with human breast cancer cells (xenografts) to induce cancer.
Prof. Mittra concludes,"Future long-term experiments should explore whether cfChP-deactivating agents given concurrently with anti-cancer treatments could help prevent metastatic spread.
When used as adjuncts to cancer treatment, these agents would have the added advantage of preventing some of the toxic side effects of chemotherapy and radiotherapy."

Global Journal Observatory: Better Understanding the Research Ecosystem

Retrieved on:

月曜日, 3月 4, 2024

BEIJING, March 4, 2024 /PRNewswire/ -- Ronald Rousseau, the Co-Editor-in-Chief of the JDIS, shared his insights as follow:

Key Points:

Science and Technology Daily has launched a new column, Global Journal Observatory, with the National Science Library of the Chinese Academy of Sciences.
For the sake of better science, the JDIS has initiated a series of activities to respond to and reverse this situation.
During the event, a memorandum of understanding was signed, signaling the collaborative effort required to safeguard the integrity of scientific research.
All of these initiatives serve our ultimate goal, that is, enabling researchers to publish the best possible scientific research to create a better life.

Maxwell Healthcare Associates, Hospice Dynamix, and Medalogix Announce Partnership

Retrieved on:

火曜日, 2月 20, 2024

Natural language processing, Hospice, AI, Intelligence, PLOS, Life, Entrepreneurship, MHA, Medicare, Health, Organization, Patient, Machine learning, Partnership, Nursing

SHOREVIEW, Minn., Feb. 20, 2024 /PRNewswire/ -- Maxwell Healthcare Associates (MHA), a leading provider in the post-acute space with an average of 20 years of experience, is proud to announce a groundbreaking partnership with Hospice Dynamix, and Medalogix.

Key Points:

SHOREVIEW, Minn., Feb. 20, 2024 /PRNewswire/ -- Maxwell Healthcare Associates (MHA), a leading provider in the post-acute space with an average of 20 years of experience, is proud to announce a groundbreaking partnership with Hospice Dynamix, and Medalogix.
"We are thrilled to embark on this tripartite partnership with Hospice Dynamix and Medalogix," said Jennifer Maxwell, Co-Founder and CEO of Maxwell Healthcare Associates (MHA).
Terry Swatley, CEO at Hospice Dynamix, expressed enthusiasm about joining forces with Maxwell Healthcare Associates (MHA) and Medalogix to serve the hospice industry.
By leveraging the collective strengths and expertise of Maxwell Healthcare Associates, Hospice Dynamix, and Medalogix, the organizations aim to transform the hospice care landscape and improve outcomes for patients and their families.

New Publication Identifies Key Proteins Involved in Amyloid Oligomer Binding and Supports Mechanism of CT1812

Retrieved on:

火曜日, 2月 6, 2024

PLOS One, SNAP, Synapse, CMO, Cognition, Microscopy, FRET, University, Protein, PLOS, Therapy, Brain, Biology, Prion, Translational Neurodegeneration, TMEM97, Doctor of Philosophy, Medical imaging

Results detected TMEM97, a protein component of the σ-2 receptor complex, in close proximity to cellular prion protein (PrPc) on Alzheimer’s brain synapses.

Key Points:

Results detected TMEM97, a protein component of the σ-2 receptor complex, in close proximity to cellular prion protein (PrPc) on Alzheimer’s brain synapses.
These findings support the hypothesis that these receptor proteins may form a complex on the synapse surface with Aβ oligomers binding to one or both proteins.
“Previous work indicated that Aβ oligomers damage synapses, but until now it was not possible to know which proteins bind toxic forms of Aβ in human synapses.
Importantly, this FRET signal is reduced in CT1812-treated mice, suggesting that CT1812 caused the release of Aβ oligomers from their binding site and prevented them from re-binding.